High-dimensional assessment of B-cell responses to quadrivalent meningococcal conjugate and plain polysaccharide vaccine.
<h4>Background</h4> <p>Neisseria meningitidis is a globally important cause of meningitis and septicaemia. Twelve capsular groups of meningococci are known, and quadrivalent vaccines against four of these (A, C, W and Y) are available as plain-polysaccharide and protein-polysaccha...
Main Authors: | O'Connor, D, Clutterbuck, E, Thompson, A, Snape, M, Ramasamy, M, Kelly, D, Pollard, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
BioMed Central
2017
|
Similar Items
-
Randomized clinical trial to evaluate the immunogenicity of quadrivalent meningococcal conjugate and polysaccharide vaccines in adults in the United kingdom.
by: Ramasamy, M, et al.
Published: (2014) -
Quadrivalent meningococcal conjugate vaccines.
by: Pace, D, et al.
Published: (2009) -
Quadrivalent meningococcal conjugate vaccines
by: Pace, D, et al.
Published: (2009) -
Meningococcal polysaccharide-protein conjugate vaccines.
by: Snape, MD, et al.
Published: (2005) -
Safety and immunogenicity of quadrivalent meningococcal polysaccharide vaccine (MPV ACYW135) compared with quadrivalent meningococcal conjugate vaccine (Menactra®) in Malian children
by: Samba O. Sow, et al.
Published: (2023-08-01)